Product Details for: Lytenava

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravitreal
1.25MG (0.05ML of 25MG/ML)
Single-Dose Vial
351(a)
Lytenava
Rx
Proper Name
bevacizumab-vikg
BLA Number
761320
Applicant
Outlook Therapeutics, Inc.
Original Approval Date
July 24, 2026
Date of First Licensure
RETURN TO SEARCH RESULTS